ReproCELL
ReproCELL Incorporated is primarily engaged in the development of stem cell technologies.
Market cap
$121m
Enterprise value
$91m
Share price
JPY167.00 4978.T
Recent deals
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | N/A | Grant | |
| Total Funding | 000k | ||
J-Startup(exited)
Nipro(exited)
DBJ Capital(exited)
Nissay Capital(exited)
JAFCO(exited)
Mitsubishi UFJ Capital(exited)
SBI Investment(exited)
| JPY | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 10 % | 7 % | 74 % | 32 % | (18 %) | 23 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (65 %) | (70 %) | (60 %) | (20 %) | (4 %) | 3 % | (3 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (55 %) | (85 %) | (63 %) | (26 %) | (10 %) | (1 %) | 3 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | - | 38 % | 51 % | 24 % | 17 % | 16 % | 18 % |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by ReproCELL
Edit
ACQUISITION by ReproCELL Aug 2014
ACQUISITION by ReproCELL Nov 2015
exited